Get the app
US › Healthcare

Alterity Therapeutics Ltd (ATHE)

US · Healthcare · Biotechnology

$2.62-3.68%
Last close · 2026-10-16

Key statistics

Market cap
$51.9M
Forward P/E
0.0
P/B
2.27
Book value
$1.64
EPS (TTM)
$-0.90
52-week high
$5.89
52-week low
$2.66
50-day MA
$4.12
200-day MA
$4.04
Beta
-0.01

Analyst view

Analysts rate Alterity Therapeutics Ltd a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $13.25.

Shareholding

Institutions
2.06%

Largest institutional holders

FundStake
Twin Lakes Capital Management, LLC0.76%
Morgan Stanley - Brokerage Accounts0.35%
Greenleaf Trust0.34%
HB Wealth Management, LLC0.32%
Citadel Advisors Llc0.21%
HRT FINANCIAL LLC0.10%
BNP Paribas Arbitrage, SA0.06%
GAMMA Investing LLC0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alterity Therapeutics Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.